How Integrated Project Delivery Enables Speed: A Phase-By-Phase Guide

Article
Pages: 18–21

By eliminating the waste involved in traditional approaches to project set-up and execution, integrated project delivery helps innovators in the European life sciences market meet their fast-track delivery targets.

Project delivery

MARTIN BERGSMA - STOCK.ADOBE.COM

The European life sciences industry is red hot. The DACH (Germany, Austria, and Switzerland) region alone, attracted nearly 20% of Europe’s biggest life sciences investments last year. With this influx of cash comes the potential for commercial success and for a new generation of advanced, life-saving therapies. To unlock that potential, though, life science innovators need more—more manufacturing capacity, more flexibility, and more expertise to get their products to market faster.

The key to ‘more’ is sometimes ‘less’: less wasted effort, more value for the project owner; less fragmentation between teams, more shared expertise. These subtle shifts are the key to delivering complex, high-value facilities faster and more cost-effectively. The shifts are not easy to embrace, but they will pay off a hundredfold for teams who successfully make the transition. That means adopting a lean culture and using it to power an integrated project delivery approach.

Read this article in BioPharm International’s November Manufacturing and Facilities 2022 eBook.

About the authors

Christian Goesker, is managing director, Thomas Lederer, is office lead, director EPCM Projects, and Mike Barrett, is vice president, Project Delivery Services, all at CRB Group.

Article details

BioPharm International
eBook: Manufacturing and Facilities
November 2022
Pages: 18–21

Citation

When referring to this article, please cite it as C. Goesker, T. Lederer, and M. Barrett, “How Integrated Project Delivery Enables Speed: A Phase-By-Phase Guide,” BioPharm International's Manufacturing and Facilities eBook (November 2022).

Recent Videos
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
© 2024 MJH Life Sciences

All rights reserved.